Increased GM‐CSF‐producing NCR(‐) ILC3s and neutrophils in the intestinal mucosa exacerbate inflammatory bowel disease

OBJECTIVES: Inflammatory bowel disease (IBD) is characterised by dysregulated mucosal immune responses associated with genetic, environmental and microbial factors. Recent therapies targeting key inflammatory mediators such as tumor necrosis factor (TNF)‐α emphasise the importance of innate immunity...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yuna, Kim, Ju Whi, Yang, Siyoung, Chung, Doo Hyun, Ko, Jae Sung, Moon, Jin Soo, Kim, Hye Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264747/
https://www.ncbi.nlm.nih.gov/pubmed/34262760
http://dx.doi.org/10.1002/cti2.1311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264747/
https://www.ncbi.nlm.nih.gov/pubmed/34262760
http://dx.doi.org/10.1002/cti2.1311

Ejemplares similares